MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KMDA — Kamada Ltd
NasdaqKamada Ltd
$8.00
-0.31(-3.73%)
- O
- 8.11
- H
- 8.13
- L
- 7.93
- V
- 137.51K
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About KMDA
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
IndustryCommon Stock
SectorNot available
IPO DateMay 31, 2013
Employees462
Stock ExchangeNasdaq
Ticker SymbolKMDA
Websitehttps://www.kamada.com
Key Financial Statistics
| Market Cap | $479.57M |
| P/E Ratio | N/A |
| Dividend Yield | 2.13% (Annual) |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $6.50 - $9.35 |
| 52-Week Avg Volume | 80.4K |
| VWAP | $8.02 |
| Transactions | 2,103 |
| Total Recorded Bars | 3,357 days |